Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy
June 1, 2019 - A new research study from the CBTP lab entitled “Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy,” was published in Neuro-Oncology Advances on May 29, 2019.


